THE DOSE

your daily dose of Innovative, trending, and groundbreaking stories from across the cosmos.


Mental Health, The Dose SykoActive Mental Health, The Dose SykoActive

the Dose

Stay Tuned for the latest in health and lifestyle innovations with SykoActive Studios. For further in-depth discussions and the latest breakthroughs, subscribe to our newsletter at www.sykoactive.com. Join us in exploring the cutting-edge developments that shape our health and everyday lives, empowering you with knowledge for a healthier tomorrow.

Read More
Psychedelics, Mental Health SykoActive Psychedelics, Mental Health SykoActive

Revolutionary Shifts in Psychedelic Therapy: A Glimpse into the Future

A series of promising studies and legislative changes are heralding what could be a transformative era in mental health treatment and the broader acceptance of psychedelic substances. From groundbreaking clinical trials to progressive policy shifts, the landscape of psychedelic therapy is rapidly evolving, offering new hope and novel approaches to persistent health challenges.

Read More
Mental Health SykoActive Mental Health SykoActive

The Psychedelic Renaissance: A New Dawn in Mental Health Treatment

The psychedelic renaissance is more than a medical revolution; it's a cultural shift towards greater openness, understanding, and compassion in the treatment of mental health. As we explore the boundless possibilities that psychedelics offer, we may find that the key to unlocking the mysteries of the mind lies in these ancient substances, reimagined for the modern age.

Read More
Mental Health, Psychedelics AIsasIA Mental Health, Psychedelics AIsasIA

Atai's Strategic Move: Investing in Beckley Psytech for Rapid-Acting Psychedelic Medicines

In an unprecedented move, Atai Life Sciences, a global biotech company, has invested a significant amount in Beckley Psytech, a company specializing in psychedelic medicine. This strategic investment marks a monumental step towards the development of rapid-acting psychedelic medicines, signifying a potential paradigm shift in mental health treatment.

Read More
Mental Health SykoActive Mental Health SykoActive

🧠 Reopening 'Critical Periods' in the Brain with Psychedelic Drugs

Neuroscientists have long been intrigued by the concept of reopening 'critical periods' in the brain, where mammals become highly receptive to signals from their environment during specific periods of brain development. Now, a groundbreaking study in mice suggests that psychedelic drugs may hold the key to unlocking these critical periods. This discovery opens up exciting possibilities for further research and potential therapeutic applications of psychedelic substances.

Read More